Electrocochleography Meniere’s Disease: When It Helps | Dr Porwal

Electrocochleography Meniere’s disease testing is used when the history suggests fluctuating ear pressure, hearing change, tinnitus, and vertigo, but the diagnosis still needs better physiological support. It can add useful evidence, but it does not confirm Meniere’s disease in isolation.

Last updated: 30 August 2026

Electrocochleography Meniere’s disease

Electrocochleography, or ECochG, is not a test most patients hear about until Meniere’s disease enters the discussion. It is usually considered when a person has episodic vertigo, fluctuating hearing symptoms, tinnitus, or aural fullness and the clinical picture needs stronger support before treatment decisions are made.

This article explains what ECochG measures, what the SP/AP ratio means, how the test fits with audiometry and other vestibular workup, and where its strengths and limitations lie. It is best understood as one part of the diagnostic picture, not a standalone answer for every dizzy patient.

An elevated SP/AP ratio may support a working diagnosis when it fits the symptom pattern and audiometry, but the value depends on the recording method and local reference range. It cannot confirm Meniere’s disease or directly measure the amount of inner-ear fluid.

This is why electrocochleography is best treated as one supportive physiological test. The result needs interpretation alongside the history, examination, hearing tests and, in selected cases, vestibular testing or specialised inner-ear MRI.

Electrocochleography — What It Tells Us About Meniere’s

What Electrocochleography Measures: Endolymphatic Hydrops

Meniere’s disease is caused by endolymphatic hydrops-excessive fluid in the membranous labyrinth of the inner ear. The inner ear normally has two fluid compartments: perilymph (outside the membranous structures) and endolymph (inside). When too much endolymph builds up, pressure increases, the delicate membranes distend, and symptoms result: vertigo attacks, fluctuating hearing loss, tinnitus, and ear fullness (the sensation of pressure in the ear).

Routine CT does not show endolymphatic hydrops, but delayed gadolinium-enhanced inner-ear MRI can demonstrate hydrops in selected centres. This specialised imaging is different from an ordinary brain or ear MRI and is not required for every patient.

Electrocochleography records sound-evoked electrical responses from the cochlea and auditory nerve. Some ECochG patterns are associated with hydrops, but the test is indirect and is influenced by hearing thresholds, electrode placement, stimulus settings and laboratory reference values.

The SP and AP: Understanding the Ratio

SP = Summating Potential (also written as DC component): An electrical potential that reflects the mechanical displacement of the basilar membrane and the deflection of hair cells. The SP is named for its property of summating (adding up) with each sound stimulus.

AP = Action Potential (also called cochlear microphonic or compound action potential): Electrical potentials generated by the firing of cochlear nerve fibers in response to sound.

In normal ears, the SP is very small compared to the AP. The SP/AP ratio is usually 0.3 to 0.4 (meaning the SP is about 30-40% of the AP in amplitude).

In Meniere’s disease with endolymphatic hydrops, the mechanical distortion from excess fluid changes the way hair cells are displaced. The SP becomes larger relative to the AP. The ratio increases to 0.5 or higher (sometimes as high as 0.6-0.8). This elevated ratio is the diagnostic hallmark of endolymphatic hydrops.

Why does this happen mechanistically? When endolymph volume increases, the endolymphatic space expands and pushes the basilar membrane toward the perilymphatic space. This increases the displacement of the basilar membrane even without sound stimulus-hence a larger SP (resting potential). Meanwhile, the AP (nerve response to sound) might be normal or decreased. Result: elevated SP/AP ratio.

An increased ratio can be supportive in the right clinical setting, but it is not a direct hydrops measurement and does not confirm Meniere’s disease. A normal result also does not exclude the diagnosis.

How Electrocochleography Is Performed

Electrode placement is the key technical detail. Different placements detect the signal better or worse:

Tympanic (extratympanic) electrode: A specialized electrode is placed on the eardrum or ear canal wall near the round window (the membrane that separates the middle and inner ear). This is the most sensitive placement because it’s closest to the source of the cochlear electrical signals. The electrode might be on the eardrum itself or just inside the canal.

External auditory canal (canal wall) electrode: Less sensitive than tympanic but still useful. Electrode placed in the ear canal.

Transtympanic electrode: A needle electrode passes through the eardrum to reach the perilymphatic space. Very sensitive but invasive, rarely used clinically.

At Prime ENT Center, we typically use a tympanic electrode placement (on or near the eardrum) because it gives the best signal-to-noise ratio without being invasive.

The test procedure:

You’ll sit in a comfortable chair. Your ear canal is carefully examined and cleaned of any cerumen (earwax) to make sure good electrode contact.

The electrode is positioned on the eardrum or medial canal wall using an otoscope-like speculum. A small topical anesthetic might be applied to reduce discomfort. This positioning is done very gently.

A reference electrode is placed on your forehead or earlobe, and a ground electrode on your neck or shoulder.

Once positioned, you’ll hear sound stimuli-usually clicks or tone-bursts at varying intensities. These stimulate the cochlea, and electrical responses are recorded through the electrodes.

Usually, responses at several sound intensities are recorded (e.g., 70, 80, 90, 100 decibels) to get a full picture. The SP and AP are measured at each level.

Duration: Usually 20-30 minutes total for both ears.

Is it uncomfortable? The electrode placement is the main discomfort. It’s not painful, but it’s somewhat uncomfortable-pressure, odd sensation. Once in place, the test itself is painless. You’ll hear sounds, that’s all. Most people tolerate it without significant difficulty.

Interpreting Electrocochleography Results

ECochG results should be interpreted against the recording method and the laboratory’s own reference data. A higher SP/AP ratio may be seen in some ears with Meniere’s disease or endolymphatic hydrops, but published cutoffs vary with electrode placement, stimulus and analysis technique.

• A value within the local reference range: does not rule out Meniere’s disease.
• A value above the local reference range: may add supportive evidence, but is not diagnostic by itself.
• Different results between ears: need correlation with symptoms, audiometry and the complete examination; they do not automatically prove unilateral or bilateral disease.

The useful clinical question is not simply whether one ratio is “positive.” It is whether the result adds reliable information to the patient’s symptom pattern and hearing findings.

New evidence — August 2026: ECochG reflects function more than a universal hydrops measure

A prospective cross-sectional study published on 25 August 2026 compared extratympanic ECochG with hearing thresholds and gadolinium-enhanced MRI in 98 ears from patients with definite Meniere’s disease. MRI-confirmed hydrops was present in 59 ears (60.2%). The SP/AP ratio was higher in ears with hydrops than without it (0.42 versus 0.24), but ECochG correlated more strongly with hearing thresholds than with hydrops severity. Its ability to distinguish MRI-confirmed hydrops was only modest, with area-under-the-curve values of 0.62-0.72.

What this means for patients: ECochG can contribute useful physiological information, but it should not be described as a test that confirms Meniere’s disease or measures a universal amount of hydrops. The study was cross-sectional, included patients who already met criteria for definite Meniere’s disease, and does not establish one cutoff for every laboratory or every dizzy patient. Read the original European Archives of Oto-Rhino-Laryngology article.

Sensitivity and Specificity of ECochG for Meniere’s Disease

Research shows electrocochleography has pretty good sensitivity for Meniere’s disease-about 50-80% depending on when in the disease course you test. In acute attacks, sensitivity might be higher (70-80%). Between attacks or in early disease, sensitivity might be lower (50-60%).

👉 Also read: Meniere’s Disease: Complete Guide to Symptoms, Diagnosis

This makes sense: endolymphatic hydrops is probably maximal during or right before an acute attack. Between attacks, fluid reabsorption might occur, making the SP/AP ratio slightly more normal.

Specificity describes how often a test is negative in people without the target condition; it is not the same as the ability of one normal result to rule out disease. Published performance varies with the ECochG method, patient group and diagnostic standard.

However, occasionally people have elevated SP/AP ratios without classic Meniere’s symptoms. This might represent subclinical hydrops or could be individual variation. So an abnormal ECochG alone doesn’t diagnose Meniere’s; it must be combined with clinical symptoms and preferably other tests.

ECochG Combined with Audiometry and Other Tests

ECochG + Audiometry: Meniere’s disease causes low-frequency hearing loss that fluctuates. If audiometry shows this pattern AND ECochG shows elevated SP/AP ratio, the diagnosis is quite strong. Together they paint a consistent picture.

ECochG + VEMP (Vestibular Evoked Myogenic Potential): These tests examine different parts of inner-ear function. Either may be abnormal in Meniere’s disease, but neither confirms the diagnosis; results must be matched to symptoms, hearing tests and examination findings.

ECochG + Caloric testing: Caloric test shows how the semicircular canals are functioning. If caloric is abnormal (reduced response) in the affected ear and ECochG shows hydrops, this suggests the hydrops is affecting canal function too.

ECochG + imaging (MRI): Delayed contrast-enhanced inner-ear MRI can sometimes demonstrate hydrops. Imaging and ECochG may provide complementary information, but hydrops can occur outside classic Meniere’s disease and the diagnosis still depends on accepted clinical criteria.

ECochG + clinical criteria: The diagnosis of Meniere’s disease is actually based on clinical criteria-the American Academy of Otolaryngology’s guidelines require: episodic vertigo (sudden onset, lasting hours), fluctuating hearing loss, tinnitus, and ear fullness. No test alone diagnoses Meniere’s. But ECochG strongly supports the diagnosis when these symptoms are present.

Cases from My Practice: ECochG in Action

Case 1: Clear Meniere’s diagnosis: A 58-year-old woman from Kanpur came with classic history-episodic severe vertigo lasting 3-4 hours, low-frequency hearing loss on audiometry, roaring tinnitus, ear fullness. She’d had three attacks over 2 months. I suspected Meniere’s. ECochG showed SP/AP ratio of 0.68 (significantly elevated). Combined with her symptoms and audiometry, the result supported the working diagnosis. I started sodium restriction, diuretic therapy, and vestibular rehabilitation. She improved remarkably.

Case 2: Diagnostic confusion: A 35-year-old man from Lucknow came with intermittent vertigo and hearing loss. Multiple doctors had different opinions-some said BPPV, some labyrinthitis, one said anxiety disorder. Audiometry showed low-frequency sensorineural hearing loss. ECochG showed SP/AP ratio of 0.72. This supported Meniere’s disease as a possibility, but did not diagnose it by itself. He started appropriate Meniere’s treatment and his symptoms improved. The combined clinical and audiological assessment helped clarify the diagnostic uncertainty.

Case 3: Borderline result: A 45-year-old woman from Hardoi with mild intermittent vertigo and tinnitus. Her hearing was normal. I suspected possible early Meniere’s or other diagnosis. ECochG showed SP/AP ratio of 0.43-borderline elevated. I counseled her to watch for development of typical Meniere’s symptoms (hearing loss, episodic vertigo), told her to see me if symptoms evolve, and didn’t start Meniere’s-specific treatment yet. A year later, she’d had no further symptoms. The borderline ECochG might have represented subclinical hydrops that never manifested clinically.

When NOT to Order ECochG

ECochG is useful, but it’s not needed for every dizzy patient. I wouldn’t order it if:

Symptoms don’t fit Meniere’s. If you have sudden one-time vertigo with no hearing loss, no tinnitus, no ear fullness-classic BPPV or vestibular neuritis pattern-ECochG is unnecessary.

Patient has active ear infection or perforation. You need a healthy eardrum for safe electrode placement. If there’s acute otitis media or a perforated eardrum, wait until it heals or work with an otologist experienced in special electrode placements.

Patient refuses the procedure. ECochG requires electrode placement on or near the eardrum, which some people find unacceptable. Respect the patient’s preference and pursue other diagnostic methods.

Diagnosis is already certain from clinical presentation and other tests. If someone has textbook Meniere’s disease with typical symptoms and findings, and hearing loss confirmed on audiometry, you might already be confident enough to start treatment without ECochG.

ECochG Cost and Availability in India

Electrocochleography is a specialized test and not available everywhere. In major cities, it costs:

for bilateral testing

Usually included as part of a detailed vestibular test battery

Not all insurance companies cover it, but some do with proper coding.

In Hardoi, we don’t have ECochG available at Prime ENT Center itself, but I can arrange it at larger diagnostic centers in the district. Results come back within 1-2 days, and I review them with the patient.

ECochG is more commonly available in major metropolitan centers (Delhi, Mumbai, Bangalore, Hyderabad) than in smaller cities. But increasing awareness and demand is driving availability in more centers across India.

Technical Considerations and Challenges in ECochG

Signal quality issues: ECochG records very small electrical signals from the cochlea. Poor electrode contact, cerumen impaction, or movement artifacts can degrade signal quality. A skilled technician is important.

Electrode displacement: Once the electrode is positioned, patient movement or talking can displace it. We ask patients to remain still during testing.

Medications that affect the test: Some medications (like loop diuretics used to treat Meniere’s) can affect the SP/AP ratio. Ideally, these would be withheld a few days before testing, but that’s not always practical. We note medication use when interpreting results.

Multiple measurements: Since SP/AP ratio can vary slightly with stimulus intensity, we measure at multiple intensity levels. This improves reliability but increases test time.

Comparison electrodes: Using a consistent reference electrode position is important for reproducible measurements. Different electrode placements might give somewhat different numbers.

The VAI Budapest 2025 Perspective on Meniere’s Diagnosis

At the VAI Budapest 2025 conference, the emphasis was on multimodal diagnosis of Meniere’s disease. No single test is 100% diagnostic. But combining clinical criteria, audiometry, ECochG, VEMP, and sometimes imaging gives high diagnostic confidence. The conference recommended that Meniere’s diagnosis should incorporate ECochG when available, especially in cases with diagnostic uncertainty.

Hearing and Balance: Why the Inner Ear Has Both Systems

You might wonder: why does the inner ear contain both the cochlea (hearing) and vestibular organs (balance)? They’re completely different functions. But evolutionarily and anatomically, they share the same fluid-filled space. They share many supporting structures.

This is why Meniere’s disease affects both hearing and balance. The excessive endolymph affects both the cochlea and the vestibular organs. Electrocochleography measures the impact on the cochlea specifically (the electrical changes reflecting fluid pressure), but it’s the same underlying pathology affecting balance too.

This is also why when If you have hearing loss in Meniere’s disease, it’s often in the low frequencies first-the parts of the cochlea that are most sensitive to mechanical displacement from endolymphatic hydrops.

FAQ Section

1. Is ECochG the same as auditory brainstem response (ABR)?

No, they’re related but different tests. ECochG measures potentials from the cochlea itself. ABR measures electrical activity from the auditory nerve and brainstem as sound travels up the auditory pathway. ECochG uses the same electrode placement and sound stimuli as ABR, but measures different parts of the signal. Sometimes they’re done together for detailed auditory assessment.

2. Will ECochG hurt?

The electrode placement is the main sensation-pressure, odd feeling, sometimes mild discomfort. Most people describe it as uncomfortable rather than painful. Once the electrode is in place, the test itself (listening to sounds) causes no discomfort. The entire experience is tolerable for most people.

3. Can I drive immediately after ECochG?

Yes. ECochG doesn’t cause vertigo or dizziness. Unlike caloric testing which can trigger transient dizziness, ECochG is safe. You can drive right after, return to work, do whatever you normally do.

4. What if I have a perforated eardrum?

Standard tympanic ECochG placement isn’t safe if the eardrum is perforated. However, an experienced otologist might be able to place the electrode carefully or use alternative placements. We’d need to see and assess the perforation first. Some ear canal placements might work even with perforation.

5. How long is the electrode left in place?

During the test, usually 20-30 minutes. Once the test is done, the electrode is immediately removed. There’s no need for the electrode to stay in. You’re done and can go about your day.

6. Can I have ECochG if I’m pregnant?

The sound stimulus during ECochG is no more intense than normal hearing tests, which are considered safe in pregnancy. However, pregnancy changes ear physiology-fluid retention, eustachian tube dysfunction, etc.-which might affect results. We usually wait until postpartum to do ECochG unless there’s an urgent clinical need. Worth discussing with your obstetrician and ENT doctor.

7. What if my ECochG shows hydrops but I have no Meniere’s symptoms?

This is possible-subclinical hydrops. Some people have endolymphatic hydrops on ECochG but don’t develop symptoms. This might progress to Meniere’s later, or might remain asymptomatic indefinitely. We watch and wait. If symptoms develop later, we treat. If they don’t develop, no treatment is needed.

8. Is ECochG covered by insurance in India?

This depends on your specific insurance plan and the diagnostic codes used. Most major insurance companies recognize vestibular testing as a legitimate diagnostic procedure. Some cover it fully, some partially, some require pre-authorization. Worth checking your policy or asking your hospital’s billing department before the test.

Taking Your ECochG Results Forward

When you have ECochG done, ask for a copy of the report and graphs. Keep it with your medical records. The SP/AP ratio number is specific and objective-useful for tracking changes if you get retested later, or for showing to other doctors.

At Prime ENT Center, I always provide ECochG results in writing and explain them verbally to every patient.

Book Your Appointment, Prime ENT Center Hardoi

If you have symptoms suggestive of Meniere’s disease-episodic vertigo, fluctuating hearing loss, tinnitus, ear fullness-Dr. Prateek Porwal can evaluate you fullly, including ECochG testing when indicated. We’ll interpret the history, examination and hearing findings, and use ECochG or other tests only when they can add useful information.

Prime ENT Center Hardoi | Phone: 7393062200 | Website: drprateekporwal.com

Diagnosing Meniere’s disease accurately requires the full clinical pattern. Electrocochleography may support that assessment, but it is not a standalone answer.

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis or prescribing guidance. Consult Dr. Prateek Porwal at Prime ENT Center, Hardoi for personalised treatment.

References

1. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. Otolaryngology–Head and Neck Surgery. 1995;113(3):181–185.
2. Thirlwall AS, Kundu S. Diuretics for Ménière’s disease or syndrome. Cochrane Database of Systematic Reviews. 2006;(3):CD003599.
3. Pullens B, van Benthem PP. Intratympanic an ototoxic antibiotic for unilateral Menière’s disease or syndrome. Cochrane Database of Systematic Reviews. 2011;(3):CD008234.
4. Liu X, Pan J, Wang W. Electrocochleographic findings in patients with Meniere’s disease: associations with hearing thresholds and endolymphatic hydrops. European Archives of Oto-Rhino-Laryngology. Published 25 August 2026. doi:10.1007/s00405-026-10558-5; PMID: 42637846.

This article is for educational purposes. Please consult Dr. Prateek Porwal at Prime ENT Center, Hardoi for personal medical advice.

Dr. Prateek Porwal is an ENT & Vertigo Specialist with over 13 years of experience, holding MBBS (GSVM Medical College), DNB ENT (Tata Main Hospital), and CAMVD (Yenepoya University). He is the originator of the Bangalore Maneuver for Anterior Canal BPPV and has published research in Frontiers in Neurology and IJOHNS. Serving at Prime ENT Center, Hardoi.

Reference: Vestibular Migraine Diagnostic Criteria — Lempert et al, 2022

Related guides: Meniere disease overview, Meniere surgery options, and vertigo diagnosis guide.

Reference: NIDCD overview of Meniere disease.